A Drug-Drug Interaction Study in Healthy Volunteers of the Effects of Tucatinib
Clinical trial NCT03723395 · COMPLETED
Trial details
- NCT number
- NCT03723395
- Sponsor
- Seagen Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-17
- Primary completion
- 2018-12-21
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.